Herba Humana - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 4,805,654 | 5,762,282 | 4,475,207 | 5,501,799 | 5,716,050 | 5,890,740 | 6,210,962 | 7,223,446 |
| Profit before tax | 423,922 | 393,318 | 365,518 | 637,530 | 554,607 | 1,024,188 | -36,212 | -11,045 |
| Net profit | 383,153 | 333,070 | 311,141 | 543,718 | 537,502 | 987,521 | -36,212 | -12,829 |
| Equity | 1,667,470 | 2,000,540 | 2,311,681 | 2,855,399 | 2,969,371 | 3,243,878 | 3,207,666 | 3,203,369 |
| Liabilities | 1,272,108 | 565,659 | 1,331,786 | 2,004,062 | 1,453,873 | 1,691,728 | 1,987,790 | 2,053,514 |
| Non-current assets | 76,313 | 73,973 | 377,232 | 427,037 | 523,215 | 487,137 | 449,802 | 574,279 |
| Current assets | 2,875,178 | 2,497,286 | 3,266,235 | 4,432,424 | 3,947,591 | 4,495,718 | 4,767,591 | 4,682,604 |
| Total assets | 2,951,491 | 2,571,259 | 3,643,467 | 4,859,461 | 4,470,806 | 4,982,855 | 5,217,393 | 5,256,883 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,016,146 | 767,850 | 866,025 |
| Social insurance contributions | - | - | - | - | - | 128,726 | 132,317 | 147,332 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +35.7% | +19.9% | -22.3% | +22.9% | +3.9% | +3.1% | +5.4% | +16.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 13.0% | 13.0% | 8.5% | 11.2% | 12.0% | 19.8% | -0.7% | -0.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 23.0% | 16.6% | 13.5% | 19.0% | 18.1% | 30.4% | -1.1% | -0.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 8.0% | 5.8% | 7.0% | 9.9% | 9.4% | 16.8% | -0.6% | -0.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 8.8% | 6.8% | 8.2% | 11.6% | 9.7% | 17.4% | -0.6% | -0.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.8 | 0.3 | 0.6 | 0.7 | 0.5 | 0.5 | 0.6 | 0.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 277,250 | 281,087 | 214,810 | 261,990 | 293,131 | 331,873 | 365,351 | 395,805 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Herba Humana - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-02-18 | 2026-02-22 | 11.63 |
| 2026-01-21 | 2026-02-04 | 11.63 |
| 2025-12-16 | 2025-12-18 | 11180.21 |
Herba Humana - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-04-18 | 2025-04-18 | 0.02 |
| 2025-04-05 | 2025-04-12 | 0.02 |
| 2025-04-04 | 2025-04-04 | 9910.72 |
| 2025-03-28 | 2025-04-03 | 0.02 |
| 2025-03-20 | 2025-03-24 | 0.02 |
| 2025-03-07 | 2025-03-12 | 40.33 |
| 2025-03-05 | 2025-03-06 | 8796.12 |
| 2025-02-28 | 2025-03-04 | 0.12 |
| 2025-02-20 | 2025-02-24 | 67.0 |
| 2024-12-30 | 2024-12-30 | 52709.24 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Herba Humana, UAB (code 123054645) is a Private Limited Liability Company engaged in the wholesale of coffee, tea, cocoa and spices. In 2025, revenue rose to €7.22M from €6.21M in 2024 and €5.89M in 2023, showing steady top-line growth across the three-year period. Profitability weakened materially: net profit fell from €987.5K in 2023 to a loss of €36.2K in 2024 and a further loss of €12.8K in 2025. The profit margin moved from 16.8% in 2023 to -0.6% in 2024 and -0.2% in 2025, indicating that the business remained close to break-even after the weaker prior year. The balance sheet remained broadly stable, with total assets at €5.26M, equity at €3.20M and liabilities at €2.05M in 2025. The equity ratio was 60.9% and debt-to-equity stood at 0.64, suggesting a relatively solid capital structure. Asset turnover was 1.37x, ROE was -0.4% and ROA was -0.2%. Revenue per employee was €401.3K, pointing to strong sales productivity.